We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
-5.07%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.94B
AUM Growth
-$256M
(-4.9%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
310
New
46
Increased
109
Reduced
88
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$52.6M |
| 2 |
UnitedHealth
UNH
|
+$48.5M |
| 3 |
Eli Lilly
LLY
|
+$40.2M |
| 4 |
Bank of America
BAC
|
+$33.6M |
| 5 |
Pfizer
PFE
|
+$32.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$55.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$45M |
| 3 |
Zimmer Biomet
ZBH
|
+$35.5M |
| 4 |
Cooper Companies
COO
|
+$35.5M |
| 5 |
Roper Technologies
ROP
|
+$31.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.89% |
| 2 | Technology | 24.22% |
| 3 | Financials | 21.01% |
| 4 | Communication Services | 9.7% |
| 5 | Consumer Discretionary | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPT
201
Medical Properties Trust
MPT
$2.86B
| $2.21M | 0.04% |
200,000
+38,130
| +24% | +$473K |
|
202
Supernus Pharmaceuticals
SUPN
$2.73B
| $2.17M | 0.04% |
154,943
+13,869
| +10% | +$258K |
|
|
SWIR
203
DELISTED
Sierra Wireless
SWIR
| $2.09M | 0.04% |
98,900
-26,100
| -21% | -$605K |
|
204
Becton Dickinson
BDX
$43.8B
| $1.99M | 0.04% |
15,375
-4,203
| -21% | -$587K |
|
205
Vertex Pharmaceuticals
VRTX
$122B
| $1.93M | 0.04% |
18,527
+8,671
| +88% | +$1.11M |
|
|
SNDK
206
DELISTED
SANDISK CORP
SNDK
| $1.9M | 0.04% |
+35,000
| New | +$1.93M |
|
207
Healthpeak Properties
DOC
$15.5B
| $1.86M | 0.04% |
+54,900
| New | +$1.9M |
|
208
Telus
TU
$16.2B
| $1.86M | 0.04% |
99,000
+9,000
| +10% | +$150K |
|
209
Omega Healthcare
OHI
$15.3B
| $1.76M | 0.04% |
50,000
| – | – |
|
210
Allot
ALLT
$373M
| $1.74M | 0.04% |
354,286
-836,005
| -70% | -$4.4M |
|
211
Sabra Healthcare REIT
SBRA
$5.65B
| $1.74M | 0.04% |
75,000
+25,000
| +50% | +$638K |
|
212
Incyte
INCY
$23.7B
| $1.69M | 0.03% |
15,278
+4,301
| +39% | +$482K |
|
|
MLNX
213
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.68M | 0.03% |
44,458
+21,225
| +91% | +$911K |
|
214
AeroVironment
AVAV
$7.81B
| $1.67M | 0.03% |
+83,350
| New | +$2.03M |
|
|
DHC
215
Diversified Healthcare Trust
DHC
$2.28B
| $1.62M | 0.03% |
100,900
| – | – |
|
|
TWO
216
Two Harbors Investment
TWO
$1.27B
| $1.59M | 0.03% |
22,500
| – | – |
|
|
AGU
217
DELISTED
Agrium
AGU
| $1.54M | 0.03% |
17,200
-3,100
| -15% | -$314K |
|
|
HR
218
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.49M | 0.03% |
60,000
| – | – |
|
219
National Health Investors
NHI
$3.84B
| $1.44M | 0.03% |
25,000
| – | – |
|
220
CVS Health
CVS
$137B
| $1.4M | 0.03% |
14,500
| – | – |
|
|
NVDQ
221
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.36M | 0.03% |
130,000
| – | – |
|
222
Healthcare Services Group
HCSG
$1.58B
| $1.29M | 0.03% |
38,372
| – | – |
|
223
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.28M | 0.03% |
12,119
+216
| +2% | +$28.9K |
|
|
MTLS
224
Materialise
MTLS
$373M
| $1.27M | 0.03% |
167,931
-28,177
| -14% | -$240K |
|
|
RDUS
225
DELISTED
Radius Health, Inc.
RDUS
| $1.25M | 0.03% |
18,052
+2,577
| +17% | +$179K |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Polar Capital held 310 positions worth $4.94B, down 4.9% from $5.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Polar Capital deployed $155M of net new capital in Q3 2015, opening 46 new positions and adding to 109 existing holdings. Its largest new stake was Allergan plc: 171,100 shares worth $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $45M trimmed.
- Polar Capital's largest Q3 2015 buy was Allergan plc: 171,100 shares worth $46.5M.
- Polar Capital added most to UnitedHealth in Q3 2015, an estimated $48.5M increase.
- Polar Capital's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $45M.
- Polar Capital fully exited Time Warner Inc in Q3 2015, selling an estimated $55.2M.
- Polar Capital's ten largest holdings make up 23% of its $4.94B portfolio in Q3 2015.
- Polar Capital opened 46 new positions and closed 39 in Q3 2015.
- Polar Capital's portfolio value fell 4.9% quarter-over-quarter to $4.94B.
Based on Polar Capital's 13F filing for Q3 2015, filed 16 Nov 2015.